Dorzolamide And Timolol Solution
Product Images NDC 69315-305

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Dorzolamide And Timolol (NDC 69315-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A (2a8d3274 3df9 4a65 A72f 086a57466c04 01)

A (2a8d3274 3df9 4a65 A72f 086a57466c04 01)
A small scientific chart or data snippet showing conditions of 25°C temperature, 405 nm wavelength, and a refractive index or related value for water at approximately -17°. The text includes measurement parameters likely related to the ophthalmic solution testing.*
FDA Label Image

C (2a8d3274 3df9 4a65 A72f 086a57466c04 02)

C (2a8d3274 3df9 4a65 A72f 086a57466c04 02)
Chemical structure diagram of Dorzolamide Hydrochloride, an active ingredient in the ophthalmic solution product Dorzolamide and Timolol. The diagram shows the molecular connections and arrangement of atoms, including sulfur, nitrogen, oxygen, and carbon.*
FDA Label Image

B (2a8d3274 3df9 4a65 A72f 086a57466c04 03)

B (2a8d3274 3df9 4a65 A72f 086a57466c04 03)
Chemical structure diagram of a compound with associated conditions including temperature (25C), acid concentration (1N HCl), and wavelength (405 nm). The image likely relates to the active ingredients in the ophthalmic solution but does not specify the compounds by name.*
FDA Label Image

F (2a8d3274 3df9 4a65 A72f 086a57466c04 04)

F (2a8d3274 3df9 4a65 A72f 086a57466c04 04)
Chemical structure diagram showing the molecular arrangement of Dorzolamide Hydrochloride and Timolol Maleate, the active ingredients in the ophthalmic solution Dorzolamide and Timolol.*
FDA Label Image

A (2a8d3274 3df9 4a65 A72f 086a57466c04 05)

A (2a8d3274 3df9 4a65 A72f 086a57466c04 05)
The image shows a small ophthalmic solution bottle of Dorzolamide and Timolol, with a white child-resistant cap. The label on the bottle contains printed text, likely including usage and safety information. The bottle is shown against a blue gradient background with the text 'Bottle as you receive it' beside it.*
FDA Label Image

B (2a8d3274 3df9 4a65 A72f 086a57466c04 06)

B (2a8d3274 3df9 4a65 A72f 086a57466c04 06)
An instructional illustration showing hands holding a small ophthalmic solution bottle labeled Dorzolamide and Timolol. The text beside the bottle instructs to snap off the dust cover by turning it clockwise to break the seal, demonstrating how to open the product for use.*
FDA Label Image

C (2a8d3274 3df9 4a65 A72f 086a57466c04 07)

C (2a8d3274 3df9 4a65 A72f 086a57466c04 07)
An instructional illustration showing a hand removing the dust cover from a small ophthalmic solution bottle labeled Dorzolamide and Timolol. The image includes an arrow indicating the cap removal direction and text instructing to "Pull off the dust cover."*
FDA Label Image

D (2a8d3274 3df9 4a65 A72f 086a57466c04 08)

D (2a8d3274 3df9 4a65 A72f 086a57466c04 08)
Instructional image showing a person unscrewing the blue colored cap from a small ophthalmic solution bottle, with a black arrow indicating the direction to unscrew, accompanied by the text instruction to unscrew the cap.*
FDA Label Image

Picto (2a8d3274 3df9 4a65 A72f 086a57466c04 09)

Picto (2a8d3274 3df9 4a65 A72f 086a57466c04 09)
An instructional illustration showing a person tilting their head backward and pulling their lower eyelid down to form a pocket for eye drops. The image includes text instructing to dispense drops with gentle pressure. This demonstrates the proper technique for administering ophthalmic solution drops.*
FDA Label Image

G (2a8d3274 3df9 4a65 A72f 086a57466c04 10)

G (2a8d3274 3df9 4a65 A72f 086a57466c04 10)
An illustration showing a person holding a small ophthalmic solution bottle of Dorzolamide and Timolol. The image highlights proper usage by instructing to replace the cap after every use and to screw the blue-colored cap down tightly on the bottle.*
FDA Label Image

Carton (2a8d3274 3df9 4a65 A72f 086a57466c04 11)

Carton (2a8d3274 3df9 4a65 A72f 086a57466c04 11)
Packaging label for Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, containing 22.3 mg / 6.8 mg per mL. The label indicates a 5 mL ophthalmic solution for topical administration in the eye, labeled Rx only. It is manufactured for Leading Pharma, LLC, and includes usage instructions with illustrations for opening and dispensing drops. Storage instructions specify 20°-25°C with permitted excursions and protection from light.*
FDA Label Image

Carton (2a8d3274 3df9 4a65 A72f 086a57466c04 12)

Carton (2a8d3274 3df9 4a65 A72f 086a57466c04 12)
Packaging label for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 22.3 mg / 6.8 mg per mL, 10 mL bottle size. The label includes directions for use, storage instructions, manufacturer information (Leading Pharma, LLC), and a depiction of a human eye. The product is indicated for topical eye administration and is prescription only (Rx Only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.